Moragas M, Soler M, Riera E, García J R
Unitat PET Esplugues de Llobregat, CETIR-ERESA Grup Mèdic, Barcelona, España.
Unitat PET Esplugues de Llobregat, CETIR-ERESA Grup Mèdic, Barcelona, España.
Rev Esp Med Nucl Imagen Mol. 2015 Jan-Feb;34(1):45-8. doi: 10.1016/j.remn.2014.02.004. Epub 2014 Mar 29.
We report a case of a patient with lung adenocarcinoma and bone and extraosseus metastases studied with (18)F-FDG PET-CT, (99m)Tc-HMDP and (18)F-fluoride PET-CT. It assesses the usefulness of (18)F-FDG PET-CT for initial staging of the disease and monitoring response to therapy. For the study of the sclerotic bone metastases it shows the superiority of 99mTc-HMDP bone scintigraphy and (18)F-fluoride PET-CT over (18)F-FDG PET-CT, and (18)F-fluoride PET-CT over bone scintigraphy. It also shows the usefulness of (18)F-fluoride PET-CT for monitoring the bone metastases.
我们报告了一例肺腺癌伴骨及骨外转移的患者，对其进行了（18）F-FDG PET-CT、（99m）Tc-HMDP及（18）F-氟化物PET-CT检查。本研究评估了（18）F-FDG PET-CT在该疾病初始分期及监测治疗反应方面的效用。对于硬化性骨转移的研究显示，99mTc-HMDP骨显像及（18）F-氟化物PET-CT优于（18）F-FDG PET-CT，且（18）F-氟化物PET-CT优于骨显像。同时也显示了（18）F-氟化物PET-CT在监测骨转移方面的效用。
